Delivery Order HHSN272201700035I-75N93022F00001
- The University of Georgia Research Foundation, Inc. was awarded a $2.46 million delivery order against the National Institute of Allergy and Infectious Diseases' (NIAID) Preclinical Models of Infectious Diseases indefinite-delivery/indefinite-quantity master contract for the production and distribution of filarial research reagents. The contract is funded by the National Institutes of Health's NIAID and will be performed in Athens, Georgia over a four-year period concluding in July 2024. Under...
- This federal contract award, valued at $1,392,486.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation). The contract is for the production and distribution of filarial research reagents data. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $146.3 million, which focuses on developing and employing animal and animal replacement models to support pandemic...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) for the Production of B. malayi Infective Larvae and Adult Worms. The contract has a potential value of $1,673,129.00 and a completion date of August 31, 2022. UGA Research Foundation is a non-profit organization that manages sponsored programs...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded the University of Georgia Research Foundation, Inc. (UGA Research Foundation) a firm fixed-price delivery order contract worth up to $722,849.00 for Task D02 Black Fly Repository Support. This contract is part of a larger $146.3 million indefinite delivery contract awarded to UGA Research Foundation in July 2024 to support NIAID's pandemic preparedness efforts through the development and use of...
- The University of Georgia Research Foundation, Inc. was awarded a $2,179,128 firm-fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract calls for the production of 110,000 Brugia malayi infective larvae or adult worms annually to support research on host-parasite interactions and immune responses, as described in the statement of work. There is no set-aside designation. Delivery...
- The University of Georgia Research Foundation, Inc. (UGA Research Foundation) was awarded a $8,142,494.82 indefinite delivery contract (IDC) from the National Institute of Allergy and Infectious Diseases (NIAID) to develop and employ animal and animal replacement models of infectious diseases to support NIAID's pandemic preparedness efforts. The IDC, named the "NIAID Preclinical Models of Infectious Diseases 2017-2024" contract, covers four main task areas: small animal models,...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation). It is a delivery order contract under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery vehicle (IDV). The contract has a firm fixed price of $518,021.00 and a period of performance through December 31, 2024. The...
- The University of Georgia Research Foundation, Inc. (UGA Research Foundation) was awarded a $1,589,085.52 firm fixed-price contract from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health for research services related to Brugia malayi adult worms and/or malayi infective larvae. This contract, which does not have a set-aside designation, is a definitive contract that runs through June 30, 2015. In July 2024, UGA Research Foundation was also...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation). The contract, titled "ANIMAL MODELS OF INFECTIOUS DISEASES," has a ceiling value of $779,623.63 and is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract (IDC). The contract does not have a...
- The University of Georgia Research Foundation, Inc. (UGA Research Foundation) was awarded a federal contract by the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over 7 years. This indefinite delivery contract focuses on developing and employing animal and animal replacement models to support NIAID's pandemic preparedness efforts, covering tasks such as small animal models, non-human primate models, animal replacement and non-traditional animal...
- HHSN272201700035IIndefinite Delivery Contract
- HHSN272201700035I-75N93022F00001Delivery Order
The National Institute of Allergy and Infectious Diseases awarded a $1.3 million base contract to the University of Georgia Research Foundation, Inc. to provide production and distribution of filarial research reagents in support of the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. The contract has a potential value of $3,961,574 and a period of performance through February 2025. There is no set-aside designation. As the prime contractor, the University of Georgia Research Foundation will leverage its experience managing federal research programs at the University of Georgia to fulfill requirements for the provision of filarial nematode reagents used in biomedical investigations into neglected tropical diseases conducted by the NIAID.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $1.3m | 2/29/24 | |
| P00001 | Exercise an Option | $1.4m | 1/24/23 | |
| Not listed | Not listed | $1.3m | 2/25/22 |